STERIS plc
STEHealthcareNASDAQMedical Devices · Last scanned Oct 26, 2026
Scan Results
Daily timeframePart of the healthcare sector, STERIS plc (STE) is listed under Medical Devices. The $22.44B market capitalization puts STE squarely in large-cap range for its industry. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.
Market Cap
$22.44B
Beta
0.93
P/E (TTM)
28.13
P/E (Fwd)
18.66
EPS (TTM)
$8.18
EPS (Fwd)
$12.33
ROE
11.4%
ROA
6.8%
Cash
$482.3M
Total Debt
$2.04B
Free CF
$798.9M
52W Change
-4.5%
Annual Financials
Cash vs Debt
Where STE stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, STE finished 2.46% above its 150-day moving average ($217.31) and 1.11% below its 200-day moving average ($225.17). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is STE overbought or oversold?
At the October 19, 2026 close, STE's RSI(14) was 70.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, STE has $482.3M in cash with $2.04B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $798.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 11.4% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.8% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $4.54B (2023) to $5.94B (2026), reflecting a 31% increase over the period.
As with any equity investment, STE carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for STERIS plc and its sector.